Job title: Oncology HEVA Business Partner – Alphamedix Launch Lead
Location: Cambridge, MA or Bridgewater, NJ
About the Job
Sanofi Specialty Care has pioneered the development and delivery of transformative therapies for patients affected by rare and debilitating diseases for over 30 years. We accomplish our goals through world-class research, collaboration with the global patient community, and with the compassion and commitment of our employees. With a focus on rare diseases, multiple sclerosis and onco-immunology, we are dedicated to making a positive impact on the lives of the patients and families we serve. Sanofi Specialty Care's portfolio of transformative therapies, which are marketed in countries around the world, represent groundbreaking and life-saving advances in medicine. Sanofi Specialty Care employees benefit from the reach and resources of one of the world's largest pharmaceutical companies, with a shared commitment to improving the lives of patients.
The US Health Economics and Value Assessment (HEVA) lead will be accountable for developing Health Economic and Outcomes Research (HEOR) plan in support of the value proposition of Alphamedix, a Radioligand therapy currently being explored in Gastroenteropancreatic neuro endocrine tumors (GEP-NET). This US HEVA launch lead role will report to Global head of oncology HEVA and will be responsible for development and execution of launch strategy & tactics in close collaboration with the cross functional teams. This role has a potential to further evolve into global Alphamedix HEVA launch lead role.
We are an innovative global healthcare company, committed to transforming the lives of people with immune challenges, rare diseases and blood disorders, cancers, and neurological disorders. From R&D to sales, our talented teams work together, revolutionizing treatment, continually improving products, understanding unmet needs, and connecting communities. We chase the miracles of science every single day, pursuing progress to make a real impact on millions of patients around the world.
Main Responsibilities:
Partner with cross functional team members to develop and support a compelling product value proposition optimizing access and reimbursement
Set clear evidence generation priorities and deliver on those in a timely manner
Work on execution of key HEVA activities (RWE, PRO analysis, Modeling, Epidemiology, dossier development and payer communication toolkit) in collaboration with the cross functional teams
Take a leadership role in the development of relationships and continued advocacy with external advisors, as appropriate.
Develop collaborative research relationships that provide data of value to decision makers.
Leverage interactions to identify strategies that will improve the impact of research and build advocates for data
Interacts with senior level management providing high level strategies and long-term vision of assigned work
Ensure feasibility of translating evidence generated into real world effectiveness and cost effectiveness arguments
Drive development of Value Dossier, from inception to dissemination and training to field teams
Serve as a resource to commercial organization in terms relative value demonstration, pricing, positioning and reimbursement of products based on economic evaluations
All incumbents are expected to demonstrate effective communication, organizational and interpersonal skills to be able to work effectively as part of a multidisciplinary team.
The incumbent is expected to work independently, but in concert with the direction provided by their management, in accordance with defined functional policies and precedents, budgetary guidelines, company values, ethics and applicable law.
Communications:
Responsible for the design of a HEVA Communication/Publication Plan with the objective to communicate the unique attributes of Oncology products to external multi-stakeholders to ensure the drug’s value proposition will be recognized and hence market access and market uptake will be maximized
About You
Key Performance Indicators:
Demonstrated contribution to product success
Development and execution of HEVA strategies and tactics that address data gaps and fulfill customer needs
Proactive communication and alignment with cross-functional stakeholders
Strong ability to partner with the project teams and develop/present HEVA strategies and options
Recognized scientific expertise and influence within cross-functional teams
Established track record of scientific publications in peer reviewed journals
Compliance with all relevant internal SOPs
Requirements:
Advanced degree (PhD, MD, MS, MPH, or PharmD) in a scientific discipline
Clinical background should be supplemented with advanced quantitative training demonstrated by an MPH or MS in a relevant field
Minimum of 7 years of combined experience in health economics, outcomes research, or market access field experience
Oncology experience strongly preferred
Track record of publications in peer-reviewed journals demonstrating experience in PROs, observational research, and/or health economics
Thorough knowledge of global HTA processes and guidelines. Direct experience in making submissions to relevant payers and interacting with them is strongly desired (in US & Europe as a minimum).
Strong ability to partner with the business unit colleagues
Demonstrated capabilities to develop global strategic HEVA plans and execute studies
Documented training in Health Economics desired
Proficiency in providing input into clinical trials
Experience with patient reported outcomes
Strong ability to partner with the business unit colleagues
Capabilities in develop global strategic HEVA plans and execute studies
Why Choose Us?
Bring the miracles of science to life alongside a supportive, future-focused team.
Discover endless opportunities to grow your talent and drive your career, whether it’s through a promotion or lateral move, at home or internationally.
Enjoy a thoughtful, well-crafted rewards package that recognizes your contribution and amplifies your impact.
Take good care of yourself and your family, with a wide range of health and wellbeing benefits including high-quality healthcare, prevention and wellness programs and at least 14 weeks’ gender-neutral parental leave.
Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.
#GD-SA
#LI-SA
#LI-Onsite
#vhd
Better is out there. Better medications, better outcomes, better science. But progress doesn’t happen without people – people from different backgrounds, in different locations, doing different roles, all united by one thing: a desire to make miracles happen. So, let’s be those people.
At Sanofi, we provide equal opportunities to all regardless of race, colour, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, ability or gender identity.
Watch our ALL IN video and check out our Diversity Equity and Inclusion actions at sanofi.com!
US and Puerto Rico Residents Only
Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally inclusive and diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; natural or protective hairstyles; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.